-
Covid-19 impact | Are Indians spending too much on immunity boosters?
Indians bought nearly Rs 15,000 crore of vitamin supplements and other immunity boosters between June 2020 to May 2021, according to AIOCD data
-
Biophore applies to DCGI for emergency-use approval for Covid treatment drug
Biophore plans to commence commercial production of Aviptadil immediately after the approval.
-
This smallcap firm zooms 5% on launch of Covid drug Favipiravir
Favipiravir inhibits and terminates viral protein synthesis and induces lethal metagenesis of influenza virus
